ING Group’s Ventyx Biosciences VTYX Stock Holding History

ING Group’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-239,000	Closed	-$2.16M	–	625
2025 Q4	$2.16M	Buy	+239,000	New	+$1.79M	0.01%	376

Other funds holding VTYX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ING Group's VTYX Position: Q1 2026 in Review

ING Group sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 239,000 shares — an estimated $2.16M sold.

ING Group first reported a position in VTYX in Q4 2025 and held it in 1 quarter. The position peaked at $2.16M in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

ING Group reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
ING Group sold 239,000 Ventyx Biosciences shares in Q1 2026, an estimated $2.16M.
ING Group first reported a position in Ventyx Biosciences in Q4 2025 and held it in 1 quarter.
ING Group's Ventyx Biosciences position peaked at $2.16M in Q4 2025.
1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on ING Group's 13F filing for Q1 2026, filed 11 May 2026.